524238 GUJINJEC

Gujarat Inject (Kerala) Share Price

 

 

Start SIP in GUJINJEC

Start SIP

Performance

  • Low
  • ₹41
  • High
  • ₹41
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹41
  • Open Price₹41
  • Previous Close₹40
  • Volume240
  • 50 DMA₹31.82
  • 100 DMA₹28.32
  • 200 DMA₹25.35

Investment Returns

  • Over 1 Month + 36.02%
  • Over 3 Month + 84.98%
  • Over 6 Month + 78.21%
  • Over 1 Year + 64.26%

Smart Investing Starts Here Start SIP with Gujarat Inject (Kerala) for Steady Growth!

Invest Now

Gujarat Inject (Kerala) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 140.7
  • PEG Ratio
  • -3.1
  • Market Cap Cr
  • 60
  • P/B Ratio
  • 5.9
  • Average True Range
  • 1.47
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.49
  • RSI
  • 82.7
  • MFI
  • 87.13

Gujarat Inject (Kerala) Financials

Gujarat Inject (Kerala) Technicals

EMA & SMA

Current Price
₹40.90
+ 1.39 (3.52%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹36.14
  • 50 Day
  • ₹31.82
  • 100 Day
  • ₹28.32
  • 200 Day
  • ₹25.35

Resistance and Support

39.54 Pivot Speed
  • R3 40.74
  • R2 40.35
  • R1 39.93
  • S1 39.12
  • S2 38.73
  • S3 38.31

Gujarat Inject (Kerala) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results
2025-05-20 Audited Results
2025-02-18 Stock Split
2025-01-23 Quarterly Results

Gujarat Inject (Kerala) F&O

Gujarat Inject (Kerala) Shareholding Pattern

0%
92.83%
7.17%

Gujarat Inject (Kerala) FAQs

Gujarat Inject (Kerala) share price is ₹40 As on 14 January, 2026 | 09:09

The Market Cap of Gujarat Inject (Kerala) is ₹59.9 Cr As on 14 January, 2026 | 09:09

The P/E ratio of Gujarat Inject (Kerala) is 140.7 As on 14 January, 2026 | 09:09

The PB ratio of Gujarat Inject (Kerala) is 5.9 As on 14 January, 2026 | 09:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23